Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Starbreeze AB (publ) half-year Q2 2019 report

Second quarter 2019 · Net sales amounted to SEK 160.0 million (123.5). SEK 137.1 million Is attributable to the sale of the publishing rights for Psychonauts 2 and 10 Crowns. PAYDAY accounted for SEK 14.4 million (31.3). · EBITDA* amounted to SEK -25,8 million (52.4). · Depreciation, amortization and impairments totaled SEK 22.0 million (46.7). · Costs related to the reconstruction amounted to SEK 12.6 million for the quarter.  · The loss before tax amounted to SEK -60.1 million (26.2). · Basic and diluted earnings per share were SEK -0.20 (0.13). · The Stockholm

Orexo signs partnership agreement with GAIA to develop and commercialize a new digital therapy for the treatment of Opioid Use Disorder

Uppsala, Sweden – August 20, 2019. Orexo AB (publ), the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, today announces it has entered into an exclusive agreement with GAIA AG (GAIA), a global leader in digital therapeutics that successfully launched its first digital health product in 2001, for a new digital therapy (DTx) for the treatment of Opioid Use Disorder (OUD). Orexo will have the exclusive global commercial rights to the product and intends to launch it in the US in 2022, subject to regulatory approval. The medically assisted treatment of

Oncopeptides appoints Klaas Bakker as new Chief Medical Officer

Stockholm - August 20, 2019 - Oncopeptides AB (Nasdaq Stockholm: ONCO) today announces that Klaas Bakker has been appointed as the new Chief Medical Officer (CMO) for Oncopeptides, starting in November.Johan Harmenberg has reached retirement age and as the company continues to expand its activities, Johan has decided to step down as CMO but continue to work as a member of the company's medical team. From 2015 to present Klaas has worked at AstraZeneca in different roles with increasing responsibility and seniority, most recently as VP Medical for their Tagrisso -TDR Franchise with global

Metsä Board’s CEO Mika Joukio will ring the NASDAQ stock market opening bell in New York today

Metsä Board Corporation press release 20 August 2019Metsä Board, part of Metsä Group, is on a roadshow in the United States meeting investors, and will participate in the NASDAQ Opening Bell Ceremony in New York today, 20 August 2019. Mika Joukio, CEO of Metsä Board, will ring the opening bell and commence the day’s trading. The ceremony will also be attended by other executives of Metsä Board and its North American customers.  “Metsä Board is Europe’s leading manufacturer of high-quality folding boxboard and white kraftliner, and the significance of Americas for our business is growing

Proact to offer cloud services to Scottish public sector as part of new framework

Data centre and cloud services provider Proact will now offer its industry-leading cloud and transition services to all public sector organisations in Scotland after being included in the Scottish Government’s Cloud Services framework. This multi-year Pan Government Collaborative Agreement, available for use by all public sector bodies in Scotland, became available on 3rd August 2019.Cloud Services is managed by the Scottish Procurement and Commercial Directorate, who lead and deliver public procurement at national, Central Government and Government levels, focusing on delivering savings,

Viking Line's half year financial report for the period 1.1.2019 - 30.6.2019

Viking Line Abp                 HALF YEAR FINANCIAL REPORT        20.8.2019 9.00 AM VIKING LINE’S HALF YEAR FINANCIAL REPORT FOR THE PERIOD 1.1.2019 -30.6.2019 Consolidated sales of the Viking Line Group for the period January 1 – June 30, 2019 were 227.0 million euros (EUR 225.7 M for the period January 1 – June 30, 2018). Operating income totalled EUR -8.8 M (-13.5). Competition in Viking Line's service area entails continued pressure on prices and volumes, which will have an adverse effect on net sales revenue per passenger. Income during the third quarter will be crucial to the

Brazilian partner Conquista Montanhismo launching collection with Polygiene Stays Fresh Technology

The climbing and outdoor company Conquista Montanhismo is a benchmark in the outdoor market in Brazil with the well-known iconic climber Edemilson Padilha as founder and CEO of the company. The products are entirely domestically produced and sold in retail throughout Brazil and online."We chose Polygiene's anti-odor treatment for both the proven efficiency and the care that Polygiene has for the environment. We are fully aligned with the values of this highly regarded company", says Edemilson Padilha, founder and CEO of Conquista Montanhismo. The launch of the collection is

Invitation to presentation of Ascelia Pharma’s Q4 report 2018/2019

Ascelia Pharma’s full-year report for the period July 2018 – June 2019 (FY 2018/2019) will be published on Thursday 22 August 2019 at 09:00 CET. A presentation for analysts, media and investors will be held the same day at 09:00 CET.The event will be hosted by the company’s CEO Magnus Corfitzen, CFO Kristian Borbos and CMO Carl Bjartmar. The presentation will be held in English.  The presentation can be followed live via the link:https://tv.streamfabriken.com/ascelia-pharma-q4-2018-2019  It will also be possible to take part of the audiocast afterwards at the same address or at

Interim report January - June 2019

RaySearch Laboratories AB (publ)“In the second quarter, order intake rose 80 percent and net sales grew 34 percent.Cash flow before financing activities increased to SEK 80 M (-49)”   SECOND QUARTER (APRIL-JUNE 2019) · Net sales SEK 189.7 M (141.0), · Profit after tax SEK 21.8 M (20.6) and earnings per share before/after dilution SEK 0.64 (0.60) · Operating profit SEK 28.8 M (26.2) · Cash flow SEK 4.1 M (-50.3) · Order intake SEK 370.6 M (206.2), · Order backlog SEK 1,043.1 M (723.5) at the end of the period HALF-YEAR (JANUARY-JUNE 2019) · Net sales SEK 362.

SDRL - Seadrill Limited Announces Second Quarter 2019 Results

Highlights• Solid operational performance in the quarter with 96% economic utilization• Revenue up 6% at $321 million with increasing reimbursable revenues• Operating Loss of $73 million• Adjusted EBITDA of $69 million• Reported net loss of $206 million equivalent to net loss per share of $2.03• Total cash of $1.5 billion following completion of the Senior Secured Notes tender offer• Order backlog of $1.9 billion as at 30 June 2019 Subsequent EventSince the end of the second quarter, Seadrill and GDI entered into a 50:50 joint venture, Gulfdrill, which will initially

Simple computational models can help predict post-traumatic osteoarthritis

Knee joint injuries, such as ligament rupture, are common in athletes. As the intact joint ligaments offer a precondition for joint stability, ligament injuries are often surgically reconstructed. However, in many cases these injuries or surgeries can lead to post-traumatic osteoarthritis. The articular cartilage, which serves to provide frictionless contact between bones, wears out completely, causing severe joint pain, lack of mobility and even social isolation. Currently, preventing the onset and development of osteoarthritis is still the best clinical course of action. Computational

NRC Group ASA – Fixed income investor meetings and contemplated bond issue

NRC Group has mandated Danske Bank to arrange a series of fixed income investor meetings in the Nordics, commencing on Monday, 26 August.  A NOK 500 million five-year senior unsecured bond issue may follow, subject to inter alia market conditions. The net proceeds from the potential bond issue will be used to refinance existing bank debt to further increase the financial flexibility. For more information, please contact: Dag Fladby, CFO of NRC Group, tlf: +47 90 89 19 35.

NRC Group - Second quarter and first half 2019 results

Today, 20 August 2019, NRC Group has released its financial results for the second quarter and first half of 2019. The company will present the results at 11.00 AM (CET) at Hotel Continental in Oslo. The presentation will be held by Henning Olsen and Dag Fladby. If you want to attend the presentation, please register by email to: ca@dnb.no. Below you will find a summary and highlights from the report. Key events -       Appointed to EUR 220 million alliance contract by City of Espoo and City of Helsinki, the largest-ever Group contract to date -       Agreement for sale of

Kungsleden to develop new 1,500 sq.m. building for Region Skåne

Kungsleden has signed an agreement with Region Skåne to develop a new building for the regional authority on the Ventilen 3 property on Ventilgatan in Malmö. Region Skåne has signed a 15-year green lease with a total rental value of approximately SEK 60 million.The lease agreement covers premises for offices and forensic psychiatric outpatient care that cover a total of approximately 1,500 sq.m. The property is located in Toftanäs on the outskirts of Malmö – a relatively new area with warehouses, logistics and offices, which offers good access to central Malmö. Region Skåne and

INTERIM REPORT FOR THE SECOND QUARTER 2019 NEW WAVE GROUP AB

PERIOD 1 APRIL – 30 JUNE 2019 · Net sales amounted to SEK 1,689.0 million, which was 11 % (6 % in local currencies) higher than last year (SEK 1,523.2 million). · Operating result amounted to SEK 119.6 (137.3) million. · Result for the period amounted to SEK 83.7 (106.8) million. · Earnings per share amounted to SEK 1.28 (1.60). · Cash flow from operating activities amounted to SEK 9.0 (124.6) million. PERIOD 1 JANUARY – 30 JUNE 2019 · Net sales amounted to SEK 3,193.9 million, which was 14 % (8 % in local currencies) higher than last year (SEK 2,796.0 million). ·

Otello Corporation announces second quarter results

Oslo, Norway - August 20, 2019 - Otello Corporation today reported financial results for the second quarter, which ended June 30, 2019. Please find the second quarter report (2Q19.pdf) and second quarter presentation (2Q19_presentation.pdf) attached.  Webcast: https://www.otellocorp.com/ir Petter Lade, CFO Phone: +47 91143878 E-mail: petterl@otellocorp.com About Otello: Otello holds shares in several different businesses, including (i) AdColony which helps publishers monetize their content through advertising and advertisers reach the audiences that build value for their

Ambea’s interim report April-June 2019

CEO comment:As we look back on the second quarter, we can see that the intensive restructuring work that commenced in Stendi in March has begun to generate results, at the same time as several steps in the integration of Aleris Omsorg were completed. We have accelerated the pace of opening new units and can see that start-ups are proceeding according to plan regarding both occupancy and a pipeline of competency. Net sales for the second quarter amounted to SEK 2,877 million (1,518). Own Management accounted for 73 per cent (68) of net sales. Adjusted EBITA rose 54 per cent year-on-year

Additional cultivation related issues identified at CannTrust

STENOCARE has received new information regarding the CannTrust cultivation process at their new greenhouse that question the validity of pesticide free declarations and future sourcing of products to STENOCARE.  The STENOCARE Board of Directors has tasked the management team with identifying additional partners for sourcing medical cannabis products for the Danish market.Since its initiation in 2018, the contractual relationship between CannTrust and STENOCARE has been based upon CannTrust’s unique ability and certification that it was able to deliver pesticide free products based upon

Open-Innovators announces the launch of Young Innovators training this September in Stockholm, Sweden

 Open-Innovators announces the launch of the Young Innovators program  to create an attractive career path for young minds interested in sustainability. The program builds upon the success of the pilot batch held in June-July this year. It is run in collaboration with industry partners and IT experts to provide training in the tools and techniques of eCommerce for promoting the Global Goals. “The program is targeted to equip enterprising young talent to learn the much-needed digital marketing skills for the promotion of the

BAKKAFROST: Operational EBIT of DKK 606 Million for the First Half of 2019

The Bakkafrost Group delivered a total operating EBIT of DKK 338.8 million in Q2 2019. Harvested volumes were 12.6 thousand tonnes gutted weight. The combined farming and VAP segments made an operational EBIT of DKK 303.4 million. The farming segment made an operational EBIT of DKK 303.4 million. Achieved prices in this quarter increased and thus had a positive effect on the operational EBIT. The VAP segment made an operational EBIT of DKK 0.0 million. The EBITDA for the FOF segment was DKK 58.4 million(Figures in parenthesis refer to the same period last year unless otherwise specified)

Invitation to presentation of Q2 2019

Norway Royal Salmon will present the interim report for the 2nd quarter 2019 on Tuesday 27th August 2019 at hrs 08:00 CET at Hotel Continental, Stortingsgaten 24/26 in Oslo. The company’s CEO Charles Høstlund and CFO Ola Loe will announce the results. Please note that the quarterly report and presentation will be published at 06:30 CET. For further information, please contact:CFO Ola LoeTlf: +47 911 79 411E-mail: ola.loe@salmon.no

ADDvise Group AB (publ) conducts a directed issue of B shares of approximately MSEK 6.0 with the aim of paying earnouts related to completed acquisitions – Regulatory information

The Board of Directors of ADDvise Group AB (publ) ("ADDvise" or the “Company"), supported by the authorization that the board of directors received at the Annual General Meeting on April 25, 2019, decided on a directed cash issue of 8,823,529 B-shares at a subscription price of 0.68 SEK per share to an institutional investor (the "Directed Issue"). Through the Directed Issue the Company receives approximately MSEK 6.0, before transaction costs. Summary · The subscription price amounts to SEK 0.68 per share, corresponding to a premium of one point forty-nine (1.49) percent compared

Nexam Chemical presents the second quarter for 2019 on August 20 at 11:00 CET

Nexam Chemical will publish the interim report for the second quarter 2019 on August 20th, 2019 at 08:30 CET. The report  and the presentation  will be available at the company website. In connection with the release - analysts, investors and media are hereby invited to a telephone conference and audio webcast at 11:00 CET where Johan Arvidsson, CEO will present and comment the report. The presentation will be held in Swedish via a conference call or audio webcast at https:

Orkla ASA: Mandatory notification of trade – primary insiders

Jaan Ivar Semlitsch, President & CEO of Orkla, has today bought 27,500 shares at an average price of NOK 80.91 per share. Following this transaction, Semlitsch and related parties own 27,500 shares in Orkla. Orkla ASAOslo, 19 August 2019Ref.:VP Investor RelationsElise HeidenreichTel.: +47 951 41 147This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

There are no items matching the current filter
There are no more items matching the current filter
Back to top